A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma
Open Access
- 1 November 2006
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 108 (9) , 3210-3215
Abstract
Randomized studies testing the clinical efficacy of platelet additive solutions (PASs) for storage of platelets are scarce and often biased by patient selection. We conducted a multicenter, randomized study to investigate clinical efficacy of platelets stored in PAS II versus plasma, also including patients with clinical complications associated with increased platelet consumption. A total of 168 evaluable patients received pooled buffy coat–derived platelet concentrates (PCs) suspended in either plasma (n = 354) or PAS II (n = 411) stored up to 5 days. Both univariate as well as multivariate analysis showed a significant effect of used storage medium in regard to 1- and 24-hour count increments and corrected count increments, in favor of plasma PCs. However, there were no significant differences between the groups regarding bleeding complications and transfusion interval. Adverse transfusion reactions occurred significantly less after transfusions with PAS II PCs (P = .04). Multivariate analysis showed no significant effect of the used storage medium on the incidence of 1- and 24-hour transfusion failure. We showed safety and efficacy of PAS II PCs in intensively treated patients; however, plasma PCs show superior increments.Keywords
This publication has 21 references indexed in Scilit:
- Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parametersVox Sanguinis, 2004
- Storage of platelets in additive solution for up to 12 days with maintenance of good in‐vitro qualityTransfusion, 2004
- Evaluation of stored plateletsVox Sanguinis, 2004
- The quality of platelets after storage for 7 daysTransfusion Medicine, 2003
- Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trialBlood, 2002
- Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solutionTransfusion, 2002
- Platelet storage in PAS-2 or autologous plasma: impact on functional parametersTransfusion Medicine, 2001
- Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*Journal of Clinical Oncology, 2001
- More on the comparison of Plasma‐Lyte A and PAS 2 as platelet additive solutionsTransfusion, 1996
- Evaluation of a new citrate‐acetate‐NaCl platelet additive solution for the storage of white cell‐reduced platelet concentrates obtained from half‐strength CPD pooled buffy coatsTransfusion, 1995